| Matthew John Hertz, ATC | |
|
1100 Fowler Ave, Berwick, PA 18603-2300 | |
| (570) 759-6400 | |
| Not Available |
| Full Name | Matthew John Hertz |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 1100 Fowler Ave, Berwick, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205340064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | RT006336 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew John Hertz, ATC 115 Woodbine Ln, Danville, PA 17821-9118 Ph: () - | Matthew John Hertz, ATC 1100 Fowler Ave, Berwick, PA 18603-2300 Ph: (570) 759-6400 |
News Archive
Marathon training is associated with improved risk factors related to cardiovascular disease among middle-aged recreational male runners, suggesting that race preparation may be an effective strategy for reducing heart disease risk, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.
pSivida Corp. has announced that after completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME (Fluocinolone Acetonide in Diabetic Macular Edema) Study continue under the current protocol, without change.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
Neogen Corporation has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.
› Verified 1 days ago
Sarah Stevens, PT, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2202 W Front St, Berwick, PA 18603 Phone: 570-752-5009 Fax: 570-752-3129 |